Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.60%
March 31, 2026 -427.8%
December 31, 2025 -1.99K%
September 30, 2025 -4.98K%
June 30, 2025 -6.88K%
March 31, 2025 -51.13%
December 31, 2024 -2.14K%
September 30, 2024 -4.24K%
June 30, 2024 -151.4%
March 31, 2024 -3.44K%
December 31, 2023 12.52%
September 30, 2023 79.23%
June 30, 2023 30.65%
March 31, 2023 -49.23%
December 31, 2022 -33.76%
September 30, 2022 3.66%
June 30, 2022 -23.76%
March 31, 2022 -37.67%
December 31, 2021 -6.19%
September 30, 2021 -37.58%
June 30, 2021 -34.21%
March 31, 2021 -49.73%
December 31, 2020 -36.93%
September 30, 2020 -1.73%
June 30, 2020 -53.94%
Date Value
March 31, 2020 -1.46%
December 31, 2019 -1.55%
September 30, 2019 17.28%
June 30, 2019 20.20%
March 31, 2019 71.12%
December 31, 2018 65.84%
September 30, 2018 74.84%
June 30, 2018 69.60%
March 31, 2018 71.48%
December 31, 2017 72.63%
September 30, 2017 81.18%
June 30, 2017 79.40%
March 31, 2017 78.88%
December 31, 2016 76.72%
September 30, 2016 80.31%
June 30, 2016 57.03%
March 31, 2016 11.35%
December 31, 2015 42.88%
September 30, 2015 76.92%
June 30, 2015 64.27%
March 31, 2015 36.55%
December 31, 2014 26.90%
September 30, 2014 66.07%
June 30, 2014 69.09%
March 31, 2014 55.70%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
Intuitive Surgical, Inc. 67.76%
Kewaunee Scientific Corp. 29.61%
STAAR Surgical Co. 71.98%

Gross Profit Margin (Quarterly) Related Metrics